
|
Rare Remedies: Navigating the Approval and
Use of Orphan Drugs in Pharmacy Practice
|
Betsy Blake PharmD, BCPS, FNAP;
Clinical Associate Professor and Director of
Interprofessional Education
USC College of Pharmacy |
Immunization Update 2025
|
Patricia H. Fabel, PharmD, BCPS, FAPhA;
Clinical Associate Professor, USC College of Pharmacy
|
|
|
Double Duty: Unveiling the Benefits of
GLP-1 Receptor Agonists
|
Jennifer Clements, PharmD,
FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM;
Clinical Professor and Director of Pharmacy Education,
USC College of Pharmacy
|
A Guide to Medication Treatment of
Depression and Anxiety Disorders
|
Jordan C. Haygood, PharmD, BCPP;
Clinical Pharmacy Specialist - Psychiatry, MUSC
|
|
![]() |
Balancing Comfort and Safety in
Post-Op Pain Management
|
Lauren Linder, PharmD, BCPP;
Senior Research Associate, Co-Director &
Clinical Pharmacy Consultant,
SCORxE Academic Detailing Service,
Division of General Internal Medicine,
Geriatrics, and Palliative, MUSC
|
Primary Care New Drug Update – 2025
|
Kelly Jones, PharmD;
Director of Outpatient Pharmacotherapy Education,
McLeod Family Medicine Program, McLeod Health
|
|
Hours | Pharmacists** | Pharmacy Technicians |
Programming From:
(Saturday, March 15)
|
6
|
$75L | $40L |
1 hours (each) | $15 | $7.50 |
- Active PEEP Preceptors: You will receive communication via email regarding discounted registration!
- USC College of Pharmacy Alumni: Prior to registering, please check your email and/or mail for information from the COP on discounted registration!
- * - For those who choose to attend in-person, fees include a continential breakfast and lunch
- L- Please note that fees will appear as “Learning Express” on your credit card statement
- Operating System: Windows, Mac OS and Linux
- Internet Browser: Internet Explorer 7.0 or higher; Mozilla Firefox 3.0 or higher; Google Chrome
- Computer Speakers or headphones connected to your computer
- Broadband Internet Connection: Cable, High-speed DSL or T1
- Monitor Screen Resolution: 320x480 or higher
- Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint and HTML
CE Hours
CE Units
Activity Type
- Knowledge-Based and Application-Based
Target Audience(s)
- Pharmacists
- Pharmacy Technicians
Accreditation(s)
![]() |
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
- Read the learning objectives and faculty disclosures
- Review the video presentation and engage in any suggested interactivity
- Complete each post-test with a score of at least 75%
- Complete the program evaluation form (Before the Home Study expiration date)
Please choose a Fee Type from the Drop Down Menu Below:
I am a
|
- Explain the regulatory process for medications used in rare disorders
- Identify challenges in developing and approving medications for rare disorders
- Recognize commonly prescribed medications for rare disorders and their indications
- Summarize the role of the pharmacist with medications for rare disorders
Speaker(s)/Author(s)
Betsy Blake, PharmD, BCPS, FNAP
|
Activity Number
0062-0000-25-012-H01-P/T
CE Hours
- Apply updates from the national immunization recommendations to patient cases
- Recall vaccine safety and efficacy data
- Compare and contrast newly approved vaccine products
- Define proper vaccine administration techniques
- Explain the technician's role in providing immunizations
- Summarize updates to national immunization recommendations
- List newly approved vaccine products
- Review proper vaccine storage and handling
Speaker(s)/Author(s)
Patricia Fabel, PharmD, BCPS
|
Activity Number
0062-0000-25-013-H06-P/T
CE Hours
- Describe the mechanism of action for glucagon-like peptide-1 (GLP-1) receptor agonists in diabetes and obesity
- Identify the additional benefits of GLP-1 receptor agonists beyond diabetes and obesity management, including mortality and morbidity outcomes
- Develop a person-centered plan incorporating GLP-1 receptor agonists with appropriate follow-up to monitor efficacy and safety
Speaker(s)/Author(s)
Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM
|
Activity Number
0062-0000-25-014-H01-P/T
CE Hours
- Review the pharmacology of medications used to treat depressive and anxiety disorders
- Summarize new treatment options for depressive and/or anxiety disorders
- Recommend an evidence-based medication regimen for patients with depressive and/or anxiety disorders
- Describe common medications used to treat depressive and anxiety disorders
- Identify new treatment options for depressive and/or anxiety disorders
- Analyze medication orders for patients with depressive and/or anxiety disorders to ensure accuracy
Speaker(s)/Author(s)
Jordan Cooler Haygood, PharmD, BCPP
|
Activity Number
0062-0000-25-015-H01-P/T
CE Hours
- Describe pre-operative screening methods of patients for preventing misuse and diversion of opioids
- Explain strategies for setting patient expectations about post-operative pain that promote conservative opioid use and enhance patient satisfaction
- Review special pain management considerations for patients on chronic opioids, including patients on medications for OUD who undergo surgery
- Formulate a surgery pain management plan for a patient on chronic opioids
- Describe pre-operative screening methods of patients for preventing misuse and diversion of opioids
- Explain strategies for setting patient expectations about post-operative pain that promote conservative opioid use and enhance patient satisfaction
- Review special pain management considerations for patients on chronic opioids, including patients on medications for OUD who undergo surgery
- Analyze medication orders for a surgery pain management plan in patients on chronic opioids
Speaker(s)/Author(s)
Lauren Linder Wier, PharmD, BCPS, BCPP
|
Activity Number
0062-0000-25-016-H08-P/T
CE Hours
- Identify new therapeutic agents recently marketed and their appropriate use
- Describe the indications, key adverse events, and precautions associated with each new therapeutic agent
- Compare and contrast new medications to others within similar therapeutic categories
- Discuss important drug interactions and pharmacokinetic parameters that are clinically relevant
- Identify new therapeutic agents recently marketed and their appropriate use
- Describe the indications, key adverse events, and precautions associated with each new therapeutic agent
- Compare and contrast new medications to others within similar therapeutic categories
- List important drug interactions associated with the new medications
Speaker(s)/Author(s)
Kelly Jones, PharmD
|
Activity Number
0062-0000-25-017-H01-P/T